Product Images Zoledronic Acid
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 4 images provide visual information about the product associated with Zoledronic Acid NDC 68083-615 by Gland Pharma Limited, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
zoledronic spl carton label
This is a description of a medication called Zoledronic Acid Injection. It is for intravenous infusion after dilution and not to be directly injected. Each single dose vial contains 4mg/5mL of zoledronic acid monohydrate, mannitol, USP, 220mg, water for injection, and sodium citrate to adjust pH. It is sterile and must not be mixed with calcium-containing infusion solutions. The pH of the injection solution is 5.7-6.7. After dilution, it can be stored under refrigeration and the total time between dilution and administration must not exceed 24 hours. The package insert contains information on dosage, administration, and preparation of the solution. The manufacturer is S Irtmiar from Hyderabad, India.*
zoledronic spl fig
This is a graph showing the proportion of complete responders in pooled HCM studies by Day 10. The x-axis shows the percentage of responders ranging from 0% to 100%, while the y-axis shows the type of treatment administered, either Zoledronic Acid Injection 4 mg or Pamidronate 90 mg. The graph indicates that the percentage of complete responders was higher for Zoledronic Acid Injection (86 responders) compared to Pamidronate (99 responders) on Day 10. P-value indicated significant difference with a value of 0.002.*
zoledronic spl structure
zoledronic spl vial label
This is a description of a medication named Zoledronic Acid Injection which is available in a 4mg/5 mL dose. The medication is for intravenous infusion only after dilution and comes in a 5 mL single dose vial. The medication should not be directly injected and should be diluted for consumption. The medication should be stored at a temperature range of 15°C to 30°C (59°F to 86°F). The package insert contains information on dosage, preparation of the solution, and administration. This medication should not be mixed with calcium-containing infusion solutions, and any unused portion should be discarded. The medication is manufactured by D.P. Pally, Dundigal Post, Hyderabad-500 043, India, and its product number is NDC 68083-116-01. The lot number and expiration date are not available.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.